EMD-73510
Structure of the human 20S proteasome in complex with a beta5-selective covalent syringolin analogue inhibitor.
EMD-73510
Single-particle2.6 Å
Deposition: 23/10/2025Map released: 15/04/2026
Last modified: 15/04/2026
Sample Organism:
Homo sapiens
Sample: Human 20S proteasome
Fitted models: 9yuz
Deposition Authors: Yan NL, Gu X
,
Fajtova P,
Tse E,
Melo A,
Southworth DR
,
O'Donoghue A,
Sello JK
,
Gestwicki JE
Sample: Human 20S proteasome
Fitted models: 9yuz
Deposition Authors: Yan NL, Gu X
,
Fajtova P,
Tse E,
Melo A,
Southworth DR
,
O'Donoghue A,
Sello JK
,
Gestwicki JE
An Optimized Route to the Syringolin Natural Products Enables Combinatorial Synthesis of Selective, Bioactive Inhibitors of the Plasmodium falciparum 20S Proteasome.
Gu X
,
Fajtova P,
Yan NL,
Saxena A,
Fei F
,
Zhu J
,
Tse E,
Melo A,
Yoo E
,
Buchwald NH,
Southworth DR
,
Bogyo M
,
Derisi JL,
Gestwicki JE
,
O'Donoghue AJ,
Sello JK
(2026) J Med Chem
,
Fajtova P,
Yan NL,
Saxena A,
Fei F
,
Zhu J
,
Tse E,
Melo A,
Yoo E
,
Buchwald NH,
Southworth DR
,
Bogyo M
,
Derisi JL,
Gestwicki JE
,
O'Donoghue AJ,
Sello JK
(2026) J Med Chem
Grant Support:
